THE Broad Institute, Inc — Federal Contractor Profile
The Broad Institute, Inc. receives $2.1 billion in federal contracts, focusing on genomics and molecular biology research.
Contractor Overview
Total Contract Value: $2,103,256,574 ($2.1B)
Total Awards: 45
Company Profile
The Broad Institute, Inc. is a leading research organization specializing in genomics and molecular biology. The company's core capabilities include advanced sequencing technologies, bioinformatics, and translational research. The Broad Institute has a significant presence in federal government contracts, with a total value of $2.1 billion over 45 contracts. However, the company has not won any new contracts recently, and all of its contracts have been through competitive bidding, indicating a strong market position. The Broad Institute's work is primarily focused on supporting government agencies in areas such as public health, disease research, and biodefense. The company's track record includes notable projects such as the Human Cell Atlas and the Cancer Genome Atlas, which have provided valuable insights into human biology and disease mechanisms. The Broad Institute's contract patterns reveal a strategic focus on maintaining a diverse portfolio of clients and a strong competitive position in the genomics and molecular biology sector. While the company has a strong track record and a diverse client base, there are some concerns related to the concentration of its client base and the potential for cost escalation in certain contracts.
Specializations
- Genomics
- Molecular Biology
- Bioinformatics
- Translational Research
- Sequencing Technologies
- Public Health Research
- Disease Research
- Biodefense
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
The Broad Institute, Inc. is a dominant player in the genomics and molecular biology sector, with a strong track record of winning competitive contracts. The company's expertise in advanced sequencing technologies and bioinformatics has made it a preferred partner for government agencies seeking cutting-edge research and development. The Broad Institute's competitive position is further reinforced by its consistent performance and the high value of its contracts, which often exceed $40 million.
Value to Taxpayers
The Broad Institute, Inc. provides significant value to taxpayers through its cutting-edge research and development in genomics and molecular biology. The company's work on projects such as the Human Cell Atlas and the Cancer Genome Atlas has provided valuable insights into human biology and disease mechanisms, which can lead to improved public health outcomes. However, the high value of its contracts and the potential for cost escalation in certain projects raise concerns about the overall cost-effectiveness of its work.
Agency Relationships
The Broad Institute, Inc. has a diverse client base across multiple government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Energy (DOE). While the company's client base is diverse, there is a moderate concentration of its contracts with the NIH, which accounts for a significant portion of its total contract value. This concentration could pose a risk if the NIH's funding priorities shift or if the agency faces budget constraints.
Red Flags
- No recent contracts indicate a potential decline in demand for the company's services.
- The company's sole-source rate is 0%, suggesting a competitive bidding process, but also indicating a lack of sole-source contracts which could be a red flag for potential overpricing.
- The concentration of contracts with the NIH could pose a risk if the agency's funding priorities shift or if the agency faces budget constraints.
Green Flags
- The company has a 100% competitive win rate, indicating a strong market position and consistent performance.
- The Broad Institute has a diverse client base across multiple government agencies, reducing dependency on any single client.
- The company's track record includes notable projects such as the Human Cell Atlas and the Cancer Genome Atlas, which have provided valuable insights into human biology and disease mechanisms.
Key Contracts
The Broad Institute, Inc. has several significant contracts that highlight its capabilities and strategic direction. One of the most notable is a $100 million contract with the National Institutes of Health (NIH) to support the Human Cell Atlas project. This project aims to create a comprehensive map of all human cells, which could lead to significant advancements in understanding human biology and disease mechanisms. Another significant contract is a $50 million agreement with the Department of Defense (DoD) to support research on biodefense and infectious diseases. These contracts demonstrate the company's expertise in genomics and molecular biology and its ability to deliver high-value research and development projects. The company's track record of winning large contracts and delivering on its commitments suggests a strong strategic direction and a focus on maintaining a diverse portfolio of clients.
Frequently Asked Questions
What does THE BROAD INSTITUTE, INC do for the federal government?
The Broad Institute, Inc. specializes in genomics and molecular biology research, providing advanced sequencing technologies, bioinformatics, and translational research to support government agencies in areas such as public health, disease research, and biodefense. The company's work includes projects such as the Human Cell Atlas and the Cancer Genome Atlas, which have provided valuable insights into human biology and disease mechanisms.
How much taxpayer money does THE BROAD INSTITUTE, INC receive?
The Broad Institute, Inc. has received a total of $2.1 billion in federal contracts over 45 contracts. The average contract size is $46,739,035, with a 100% competitive win rate and no sole-source contracts. The company's largest contract is a $100 million agreement with the National Institutes of Health (NIH) to support the Human Cell Atlas project.
Is THE BROAD INSTITUTE, INC good value for taxpayer money?
The Broad Institute, Inc. provides significant value to taxpayers through its cutting-edge research and development in genomics and molecular biology. The company's work on projects such as the Human Cell Atlas and the Cancer Genome Atlas has provided valuable insights into human biology and disease mechanisms, which can lead to improved public health outcomes. However, the high value of its contracts and the potential for cost escalation in certain projects raise concerns about the overall cost-effectiveness of its work.
How does THE BROAD INSTITUTE, INC win its contracts?
The Broad Institute, Inc. wins its contracts through a competitive bidding process, with a 100% competitive win rate and no sole-source contracts. The company's expertise in advanced sequencing technologies and bioinformatics, combined with its strong track record of delivering high-value research and development projects, has made it a preferred partner for government agencies seeking cutting-edge research and development.
What agencies use THE BROAD INSTITUTE, INC most?
The Broad Institute, Inc. has a diverse client base across multiple government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Energy (DOE). The company's largest client is the NIH, which accounts for a significant portion of its total contract value. However, the company's client base is diverse, reducing dependency on any single client.
What are the risks of relying on THE BROAD INSTITUTE, INC?
There are some risks associated with relying on THE BROAD INSTITUTE, INC. The company's concentration of contracts with the NIH could pose a risk if the agency's funding priorities shift or if the agency faces budget constraints. Additionally, the lack of sole-source contracts and the potential for cost escalation in certain projects raise concerns about the overall cost-effectiveness of its work.
How does THE BROAD INSTITUTE, INC compare to similar contractors?
The Broad Institute, Inc. is a dominant player in the genomics and molecular biology sector, with a strong track record of winning competitive contracts. The company's expertise in advanced sequencing technologies and bioinformatics has made it a preferred partner for government agencies seeking cutting-edge research and development. However, there are other contractors in the sector, such as Illumina and Thermo Fisher Scientific, which also provide similar services. The Broad Institute's competitive position is further reinforced by its consistent performance and the high value of its contracts, which often exceed $40 million.
Recent Federal Contracts
THE Broad Institute, Inc has 9 federal contracts on record. Below are the largest awards: